Daiwa Securities Group’s Immunogen Inc IMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-1,094
| Closed | -$32K | – | 1369 |
|
|
2023
Q4 | $32K | Buy |
1,094
+206
| +23% | +$4.1K | ﹤0.01% | 1100 |
|
|
2023
Q3 | $14K | Hold |
888
| – | – | ﹤0.01% | 1114 |
|
|
2023
Q2 | $17K | Hold |
888
| – | – | ﹤0.01% | 1110 |
|
|
2023
Q1 | $3K | Hold |
888
| – | – | ﹤0.01% | 1199 |
|
|
2022
Q4 | $4K | Buy |
888
+195
| +28% | +$1.06K | ﹤0.01% | 1176 |
|
|
2022
Q3 | $3K | Hold |
693
| – | – | ﹤0.01% | 1211 |
|
|
2022
Q2 | $3K | Hold |
693
| – | – | ﹤0.01% | 1215 |
|
|
2022
Q1 | $3K | Hold |
693
| – | – | ﹤0.01% | 1233 |
|
|
2021
Q4 | $5K | Hold |
693
| – | – | ﹤0.01% | 1208 |
|
|
2021
Q3 | $4K | Buy |
693
+309
| +80% | +$1.78K | ﹤0.01% | 1203 |
|
|
2021
Q2 | $3K | Hold |
384
| – | – | ﹤0.01% | 1125 |
|
|
2021
Q1 | $3K | Hold |
384
| – | – | ﹤0.01% | 1125 |
|
|
2020
Q4 | $2K | Sell |
384
-612
| -61% | -$3.57K | ﹤0.01% | 1145 |
|
|
2020
Q3 | $4K | Buy |
996
+151
| +18% | +$610 | ﹤0.01% | 1109 |
|
|
2020
Q2 | $3K | Hold |
845
| – | – | ﹤0.01% | 1149 |
|
|
2020
Q1 | $3K | Hold |
845
| – | – | ﹤0.01% | 1148 |
|
|
2019
Q4 | $4K | Sell |
845
-110
| -12% | -$373 | ﹤0.01% | 1137 |
|
|
2019
Q3 | $2K | Buy |
955
+224
| +31% | +$595 | ﹤0.01% | 1140 |
|
|
2019
Q2 | $2K | Hold |
731
| – | – | ﹤0.01% | 1159 |
|
|
2019
Q1 | $2K | Hold |
731
| – | – | ﹤0.01% | 1146 |
|
|
2018
Q4 | $4K | Hold |
731
| – | – | ﹤0.01% | 1078 |
|
|
2018
Q3 | $7K | Hold |
731
| – | – | ﹤0.01% | 1068 |
|
|
2018
Q2 | $7K | Hold |
731
| – | – | ﹤0.01% | 1078 |
|
|
2018
Q1 | $8K | Buy |
+731
| New | +$7.22K | ﹤0.01% | 1050 |
|
Other funds holding IMGN
Daiwa Securities Group's IMGN Position: Q1 2024 in Review
Daiwa Securities Group sold out of Immunogen Inc (IMGN) in Q1 2024, closing a stake of 1,094 shares — an estimated $32K sold.
Daiwa Securities Group first reported a position in IMGN in Q1 2018 and held it in 24 quarters. The position peaked at $32K in Q4 2023. 3 funds tracked by Wall St. Rank hold IMGN as of Q1 2024.
- Daiwa Securities Group reported no remaining Immunogen Inc position as of Q1 2024 after selling out during the quarter.
- Daiwa Securities Group sold 1,094 Immunogen Inc shares in Q1 2024, an estimated $32K.
- Daiwa Securities Group first reported a position in Immunogen Inc in Q1 2018 and held it in 24 quarters.
- Daiwa Securities Group's Immunogen Inc position peaked at $32K in Q4 2023.
- 3 funds tracked by Wall St. Rank held Immunogen Inc as of Q1 2024.
Based on Daiwa Securities Group's 13F filing for Q1 2024, filed 2 May 2024.